Graceful Touch marketed 'Herpes B Gone' cream as an unapproved new drug for herpes and STI symptoms, FDA says.
What happened
FDA reviewed the website https://gracefultouchproducts.org/ in July 2026. It found the 'Herpes B Gone' page used claims about herpes sores and 'lower the dangers of herpes virus,' making the product a drug. FDA says no approved application is in effect, so the product is an unapproved new drug.
What FDA found
The website claims show 'Herpes B Gone' is intended to treat, cure, mitigate, or prevent disease or affect body function, so it is a drug.
Section 201(g)(1) of the FD&C Act, 21 U.S.C. 321(g)(1)'Herpes B Gone' is a new drug because it is not generally recognized as safe and effective for its labeled uses.
Section 201(p) of the FD&C Act, 21 U.S.C. 321(p)No FDA-approved application is in effect for this product.
Section 505(a) of the FD&C Act, 21 U.S.C. 355(a)Introducing or delivering the unapproved drug into interstate commerce violates the FD&C Act.
Sections 301(d) and 505(a) of the FD&C Act, 21 U.S.C. 331(d) and 355(a)
What FDA wants
FDA tells the company to send a written response to FDAAdvisory@fda.hhs.gov within 15 business days. The response must include steps taken to correct violations, steps to prevent recurrence, and related documentation, with reference number 735272 in the subject line.
Who should pay attention
- online sellers of plant-based creams with disease-treatment claims
- retailers and marketplaces listing OTC STI products
- consumers who use OTC creams for herpes symptoms
This is a summary. Read the original letter on fda.gov.